HSPD1P13

Across TCGA pan-cancer cohorts, HSPD1P13 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated HSPD1P13 data layer.

The strongest signal is observed in kidney chromophobe (KICH), where higher HSPD1P13 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated HSPD1P13 expression acts as an unfavorable survival marker, although some lineages such as LUAD and LGG show a favorable association.

KICH, STAD, and UCEC are the cancer types where HSPD1P13 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KICH	DFS	Tertile	All	0.035	0.904	<.001	90	view →
STAD	DFS	Quartile	II,III,IV	0.203	0.434	.002	78	view →
UCEC	DFS	Tertile	All	0.630	0.854	<.001	72	view →
READ	OS	Tertile	III,IV	0.555	0.890	<.001	60	view →
LIHC	DFS	Tertile	II,III,IV	0.058	0.421	<.001	54	view →
LUAD	OS	Tertile	All	0.925	0.760	.015	39	view →
SARC	OS	Tertile	All	0.535	0.843	.009	27	view →
LGG	OS	Tertile	All	0.877	0.751	.001	23	view →
COAD	OS	Tertile	III,IV	0.163	0.791	.004	18	view →
ACC	OS	Tertile	III,IV	0.271	0.610	.038	15	view →
UCS	OS	Tertile	II,III,IV	1.000	0.417	.017	12	view →
ESCA	OS	Quartile	All	0.499	0.701	.024	5	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

HSPD1P13–KICH (DFS)

Open the KICH breakdown →